Pathstone Family Office’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$50.8M Buy
438,779
+787
+0.2% +$109K 0.39% 45
2023
Q2
$69.1M Buy
437,992
+1
+0% +$151 0.98% 21
2023
Q1
$76.7M Sell
437,991
-439,069
-50% -$73.8M 1.24% 16
2022
Q4
$119M Sell
877,060
-1,316
-0.1% -$173K 1.01% 19
2022
Q3
$108M Buy
878,376
+440,346
+101% +$58.9M 0.98% 27
2022
Q2
$61.4M Buy
438,030
+705
+0.2% +$98.7K 1.35% 17
2022
Q1
$65.8M Buy
437,325
+392,771
+882% +$62.8M 1.53% 17
2021
Q4
$9.2M Sell
44,554
-9,904
-18% -$1.82M 0.23% 54
2021
Q3
$7.63M Buy
54,458
+34,767
+177% +$5.22M 0.22% 54
2021
Q2
$3.02M Buy
19,691
+51
+0.3% +$7.13K 0.09% 112
2021
Q1
$2.77M Hold
19,640
0.09% 101
2020
Q4
$2.5M Buy
+19,640
New +$2.21M 0.1% 79

Other funds holding SLAB

Pathstone Family Office's SLAB Position: Q3 2023 in Review

Pathstone Family Office increased its Silicon Laboratories (SLAB) stake by 0.18% in Q3 2023, buying an estimated $109K and bringing the position to 438,779 shares worth $50.8M. The position accounts for 0.39% of the portfolio, ranked #45.

Pathstone Family Office first reported a position in SLAB in Q4 2020 and has held it in 12 quarters since. The position peaked at $119M in Q4 2022. 323 funds tracked by Wall St. Rank hold SLAB as of Q3 2023.

  • Pathstone Family Office held 438,779 shares of Silicon Laboratories worth $50.8M as of Q3 2023.
  • Pathstone Family Office bought 787 Silicon Laboratories shares in Q3 2023, an estimated $109K.
  • Silicon Laboratories made up 0.39% of Pathstone Family Office's portfolio in Q3 2023, its #45 holding.
  • Pathstone Family Office first reported a position in Silicon Laboratories in Q4 2020 and has held it in 12 quarters since.
  • Pathstone Family Office's Silicon Laboratories position peaked at $119M in Q4 2022.
  • 323 funds tracked by Wall St. Rank held Silicon Laboratories as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.